IRCT2017020120258N30已完成2 期
The effects of Filgrastimin on Complications of patients with cerebral hemorrhage ?due to head trauma ?
Vice chancellor for research, Arak University of Medical Sciences0 个研究点目标入组 68 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •18 years and more; patients with cerebral hemorrhage due to head trauma; level of consciousness between 9 -13
- •Exclusion criteria: alcohol consumption and addiction; allergy for drug; history of hypertension and diabetes and embolism and deep vein thrombosis; patient died 72 hours after admission
排除标准
- 未提供
研究者
相似试验
招募中
2 期
The Effects of Filgrastim on Prognosis of Patients with acute Ischemic StrokeIRCT20141209020258N63Arak University of Medical Sciences84
已完成
2 期
The comparison of effects of two drugs in neutropenic patientseutropenia.NeutropeniaIRCT201205279875N1Cinnagen Drug Corporation66
尚未招募
3 期
Comparison of the effect of pegfilgrastim with filgrastim on the neutrophil count of cancer patients under chemotherapy.IRCT20180119038433N3Semnan University of Medical Sciences60
进行中（未招募）
1 期
Evaluating the Therapeutic Efficacy of Filgrastim in Severe Bullous Drug Eruptions (Lyell and Stevens-Johnson Syndromes)CTIS2024-515275-35-00Hospices Civils De Lyon42
进行中（未招募）
不适用
PEG-Filgrastim versus Filgrastim as an adjunct to therapy CHOP-14 Rituximab in elderly patients 60-75 years old with B cell non-Hodgkin s High/intermediate grade lymphoma. A randomized, prospectic, multicenter, open-label, phase II study.Maintenance of dose-intensityMedDRA version: 6.1Level: HLGTClassification code 10025320EUCTR2005-004646-13-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI50